Vivos Inc.
OTC: RDGL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael K. Korenko
- Employees
- 1
- Headquarters
- Kennewick, United States
- IPO year
- 1998
- Market cap
- $29.6M
- Website
- https://www.radiogel.com
Loading RDGL…
Loading profile data…Frequently asked questions about RDGL
What does Vivos Inc. (RDGL) do?
Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both...
Where does RDGL trade?
Vivos Inc. (RDGL) trades on the Other OTC.
What sector is RDGL in?
Vivos Inc. (RDGL) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Vivos Inc.?
Michael K. Korenko is the chief executive officer of Vivos Inc. (RDGL).
Where is Vivos Inc. headquartered?
Vivos Inc. is headquartered in United States.
Does RDGL pay a dividend?
Vivos Inc. (RDGL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RDGL go public?
Vivos Inc. (RDGL) completed its initial public offering in 1998.